The African digital renaissance is giving a long lasting promise to the shrewd international investors. 10 years of rapid growth of economy in Africa is an excellent platform where the consumer expenditures are increasing to levels exceeding $1 trillion every year. This is estimated to continue to the year 2020 as reported by Forbes magazine. Therefore, any astute investor should seize this excellent opportunity already presented by Africa.

Continue reading

Africa is home to many attractive wildlife sceneries than any other part of the world. However, the wildlife is facing the risk of extinction due to the increased poaching activities especially on elephants and rhino tasks and skins. It seems like the efforts by African governments to curb poaching are no bearing any positive results. Perhaps it’s time that Africa resort to technology to turn around the state of fighting a losing battle.

The war on poaching can best be fought through technology and many several African states are taking the new technology driven path. For instance in the sub-Saharan African countries such as Kenya, rhinos are fitted with Global Positioning System (GPS) trackers, spy cameras and heart rate monitors to track their activities and location. These tracking devices are embedded in the horns. These and many high-tech but small devices are a game changer in the fight against poaching in Africa.

Continue reading

In an age of technological breakthroughs, biometric technology is becoming part and parcel of daily living. Many institutions globally are implementing the biometric technology, especially the fingerprint technology. In healthcare sectors, biometric fingerprint technology has proven to be a useful tool in solving some of the complex problems that regions with limited resources face.
In Africa, identification of patients within health services is a tough operational challenge. This is not only true for African countries but also other parts of the globe facing resource limitations. For instance, when tracking groups that are prone to HIV risks for provision of service or in the vaccine trial context, misidentification of patients can result to harm and trial outcomes that are biased.

Continue reading